This year’s conference, on October 9, will include presentations on the progress of research from ALS TDI’s science team, a panel discussion with ALS TDI researchers and industry collaborators from across the ALS research community, and expert-led guest presentations.

The ALS Therapy Development Institute (ALS TDI) is proud to announce that it will lead all research operations for Champion Insights—a new study planned to launch this fall in partnership with Answer ALS and Augie’s Quest to Cure ALS. This effort aims to uncover critical genetic and metabolic factors that may help explain the significantly higher incidence of amyotrophic lateral sclerosis (ALS) among endurance athletes, military service members, and other potentially high-risk groups.

ALS TDI's Development Director, Michele Dupree, will once again serve as the VIP Concierge for attendees with ALS at the upcoming ALS TDI Leadership weekend in Boston – including the ALS TDI Summit on October 9th and the White Coat Affair on the 10th.